Ledger.Open graph →
SEC Form D · Amendment · filed May 16, 2018

FOG PHARMACEUTICALS, INC

Offering
$66.0M
Sold
$65.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Gregory L. Verdine · Cambridge, MAExec · DirectorJeffrey A. Leerink · Cambridge, MADirectorWeiqing M. Zhou · Cambridge, MAExecLeon A. Chen · Cambridge, MADirectorEdward M. Fitzgerald · Cambridge, MADirectorRodney Thompson · Boulder, COExecBarry Gainsburg · Plantation, FLDirectorJennifer Myung · Boulder, CODirectorAnselme Le Van · Mountain View, CAExec · DirectorVal Dziedzic · Boulder, CODirectorMargaret Regalia · Englewood, COExec · DirectorKevin Morelli · Savannah, GADirectorBrent Watts · Savannah, GADirectorMagnus Hillestad · Palo Alto, CAExecSimen S. Skogsrud · Palo Alto, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗